Abstract
In everyday practise, more than 80% of pregnant women receive one at least medication, often for ENT causes. The aim of the present paper is to review the literature on safety and administration of medical treatment for ear diseases, in pregnant women. The literature review includes Medline and database sources. Electronic links, related books and written guidelines were also included. The study selection was as follows: controlled clinical trials, prospective trials, case-control studies, laboratory studies, clinical reviews, systematic reviews, metanalyses, and case reports. The following drugs are considered relatively safe: beta-lactam antibiotics (with dose adjustment), macrolides (although the use of erythromycin and clarithromycin carries a certain risk), and acyclovir. Non-selective NSAIDs (until the 32nd week), nasal decongestants (with caution and up to 7 days), intranasal corticosteroids, with budesonide as the treatment of choice, first generation antihistamines, or cetirizine (third trimester) and loratadine (second and third trimester) from the second generation, H2 receptor antagonists (except nizatidine) and proton pump inhibitors (except omeprazole), can be used to relieve patients from the related symptoms. Meclizine and dimenhydrinate, as antiemetics in vertigo attacks; metoclopramide, vitamin B6 and ginger rhizome, alternatively. Low-dose diazepam and diuretics in severe cases of Meniere’s disease (with caution). Systemic administration of prednisone and prednisolone can be considered in selected cases. By contrast, selective COX-2 inhibitors, betahistine and vasodilating agents are contraindicated in pregnancy. Since otologic and neurotologic manifestations during pregnancy tend to seriously affect the quality of life of the expectant mothers, ENT surgeons should familiarise themselves with the basic guidelines and safety precautions for any related medication, in order to provide appropriate treatment.
Similar content being viewed by others
References
Holt GR, Mabry RL (1983) ENT medications in pregnancy. Otolaryngol Head Neck Surg 91:338–41
Abrams RS (1990) Will it hurt the baby? The safe use of medications during pregnancy and breastfeeding. Addison-Wesley, Reading, pp 1–5
Rubin PC (1986) Prescribing in pregnancy. General principles. BMJ 293:1415–1417
Moore KL (1988) The developing human: clinically oriented embryology, 4th edn. W.B. Saunders, Philadelphia, p 131
Schatz M (1997) Asthma treatment during pregnancy. What can be safely taken? Drug Saf 16(5):342–350
Ekelund H, Kullander S, Kallen B (1970) Major and minor malformations in newborns and infants up to one year of age. Acta Paediatr Scand 59:297–302
Ash P, Vennart J, Carter CO (1977) The incidence of hereditary disease in man. J Med Genet 14:305
Sa del Fiol F, Gerenutti M, Groppo FC (2005) Antibiotics and pregnancy. Pharmazie 60(7):483–493
Goodnight WH, Soper DE (2005) Pneumonia in pregnancy. Crit Care Med 33(10 Suppl):S390–S397
Lim WS, Macfarlane JT, Colthorpe CL (2003) Treatment of community-acquired lower respiratory tract infections during pregnancy. Am J Respir Med 2(3):221–233
Miller EL (2002) The penicillins: a review and update. J Midwifery Womens Health 47(6):426–434
Christensen B (2000) Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 46(Suppl 1):29–34 discussion 63–65
Rouveix B, Levacher M, Giroud JP (1999) Drugs for respiratory tropism and pregnancy (article in French). Rev Pneumol Clin 55(5):338–343
Garland SM, O’Reilly MA (1995) The risks and benefits of antimicrobial therapy in pregnancy Drug Saf 13(3):188–205
Friese K (1993) Antibiotic therapy in pregnancy (article in German). Immun Infekt 21(4):111–114
Leophonte P (1988) Antibiotics during pregnancy and breast feeding: consequences for the treatment of respiratory infections. Rev Mal Respir 5(3):293–298
Ellegard EK (2004) Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol 26(3):149–159
Heikkila A, Erkkola R (1994) Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules. Clin Pharmacokinet 27(1):49–62
Mucklow JC (1986) The fate of drugs in pregnancy. Clin Obstet Gynaecol 13(2):161–175
Brocklehurst P (2002) Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev (2):CD000098
Di Lorenzo G, Mansueto P, Melluso M, Purello D’Ambrosio F, Putignano E, Barbagallo Sangiorgi G (1994) Allergy in pregnancy (article in Italian). Clin Ter 145(9):223–229
Sarkar M, Woodland C, Koren G, Einarson AR (2006) Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 6(5):18
Källén BA, Otterblad Olausson P, Danielsson BR (2005) Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20(2):209–214
Källén BA, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17(3):255–261
Czeizel A, Rockenbauer M, Sørensen HT, Olsen J (1999) A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 13(6):531–536
Louik C, Werler MM, Mitchell AA (2002) Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 186(2):288–290
Amsden GW (1996) Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 18(1):56–72 discussion 55
Chun JY, Han JY, Ahn HK, Choi JS, Koong MK, Nava-Ocampo AA, Koren G (2006) Fetal outcome following roxithromycin exposure in early pregnancy. J Matern Fetal Neonatal Med 19(3):189–92
Bogacka E (1999) Decongestants in treatment of nasal obstruction (article in Polish/abstract). Otolaryngol Pol 53(3):347–352
Mazzotta P, Loebstein R, Koren G (1999) Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf 20(4):361–375
Naclerio RM (1998) Optimizing treatment options. Clin Exp Allergy 28(Suppl 6):54–59
Gilbert C, Mazzotta P, Loebstein R, Koren G (2005) Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 28(8):707–719
Keles N (2004) Treatment of allergic rhinitis during pregnancy. Am J Rhinol 18(1):23–28
Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D (1997) The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 100(3):301–306
Demoly P, Piette V, Daures JP (2003) Treatment of allergic rhinitis during pregnancy (article in French). Drugs 63(17):1813–1820
Gilbert-Barness E, Drut RM (2000) Association of sympathomimetic drugs with malformations. Vet Hum Toxicol 42(3):168–171
Ugen KE, Scott WJ Jr (1987) Reduction of uterine blood flow by phenylephrine, an alpha-adrenergic agonist, in the day 11 pregnant rat: relationship to potentiation of acetazolamide teratogenesis. Teratology 36(1):133–141
No authors listed (2000) The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). Ann Allergy Asthma Immunol 84(5):475–480
No authors listed (2004) Gastroschisis and pseudoephedrine during pregnancy. Prescrire Int 13(72):141–143
Werler MM (2006) Teratogen update: pseudoephedrine. Birth Defects Res A Clin Mol Teratol 76(6):445–452
Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ (1996) Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54(2):84–92
Werler MM, Mitchell AA, Shapiro S (1992) First trimester maternal medication use in relation to gastroschisis. Teratology 45(4):361–367
Blaiss MS (2003) Food, drug administration (US); ACAAI–ACOG (American College of Allergy, Asthma, and Immunology and American College of Obstetricians and Gynecologists). Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol 90(6 Suppl 3):16–22
Gluck PA, Gluck JC (2005) A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 21(7):1075–1084
Osur SL (2005) The management of asthma and rhinitis during pregnancy. J Womens Health (Larchmt) 14(3):263–276
Gani F, Braida A, Lombardi C, Del Giudice A, Senna GE, Passalacqua G (2003) Rhinitis in pregnancy. Allerg Immunol (Paris) 35(8):306–313
Paris-Kohler A, Megret-Gabeaud ML, Fabre C, Mares P, Vincent D (2001) The allergic pregnant woman (article in French). Allerg Immunol (Paris) 33(10):399–403
Bothamley G (2001) Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 24(7):553–565
Shehata H, Nelson-Piercy C (2001) Drugs to avoid. Best Pract Res Clin Obstet Gynaecol 15(6):971–986
Ostensen ME, Skomsvoll JF (2004) Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 5(3):571–80
Fardet L, Nizard J, Genereau T (2002) Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding (article in French). Presse Med 31(31):1462–1468
Burdan F, Belzek A (2001) Current opinions on embryotoxic and teratogenic effects of ibuprofen (article in Polish/abstract). Pol Merkuriusz Lek 11(63):266–270
Ostensen M (1998) Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol Suppl 107:128–132
Ostensen M, Ramsey-Goldman R (1998) Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 19(5):389–410
Ostensen M (1994) Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet 27(6):486–503
Schoenfeld A, Bar Y, Merlob P, Ovadia Y (1992) NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 28(3–4):141–147
Burdan F (2001) Prenatal effects of acetylsalicylic acid (article in Polish/abstract). Pol Merkuriusz Lek 11(62):182–186
De Santis M, Carducci B, Cavaliere AF, De Santis L, Straface G, Caruso A (2001) Drug-induced congenital defects: strategies to reduce the incidence. Drug Saf 24(12):889–901
Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 160(5):610–619
Gran JT, Ostensen M (1998) Spondyloarthritides in females. Baillieres Clin Rheumatol 12(4):695–715
Pfaffenrath V, Rehm M (1998) Migraine in pregnancy: what are the safest treatment options? Drug Saf 19(5):383–388
Werler MM, Sheehan JE, Mitchell AA (2002) Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155(1):26–31
Ericson A, Källén BA (2001) Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 15(4):371–375
Yodfat Y (2004) Is there a future for COX-2 inhibitors? (article in Hebrew/abstract) Harefuah 143(11):820–824 837
Chan VS (2004) A mechanistic perspective on the specificity and extent of COX-2 inhibition in pregnancy. Drug Saf 27(7):421–426
Bannwarth B, Pehourcq F (2003) Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs 63(2):5–13
Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, Bortnik O, Arnon J, Ornoy A (2004) First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 58(3):298–302
Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 97(2):188–192
Fairbanks DNF (2003) Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery, 11th edn. American Academy of Otolaryngology-Head and Neck Surgery Foundation
Loh KY, Sivalingam N (2005) Understanding hyperemesis gravidarum. Med J Malaysia 60(3):394–399. Quiz 400
Nelson-Piercy C (1998) Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken? Drug Saf 19(2):155–164
Magee LA, Mazzotta P, Koren G (2002) Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 186(5 Suppl Understanding):S256–S261
Flake ZA, Scalley RD, Bailey AG (2004) Practical selection of antiemetics. Am Fam Physician 69(5):1169–1174
Leathem AM (1986) Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. Clin Pharm 5(8):660–668
Schroder O, Stein J (2002) Vomiting in pregnancy. When is it more than only a bothersome nuisance? (article in German). MMW Fortschr Med 144(50):32–34
Jewell D, Young G (2003) Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev (4):CD000145
Langner E, Greifenberg S, Gruenwald J (1998) Ginger: history and use. Adv Ther 15(1):25–44
Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA (2005) Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105(4):849–856
Betz O, Kranke P, Geldner G, Wulf H, Eberhart LH (2005) Is ginger a clinically relevant antiemetic? A systematic review of randomized controlled trials (article in German). Forsch Komplementarmed Klass Naturheilkd 12(1):14–23
Bryer E (2005) A literature review of the effectiveness of ginger in alleviating mild-to-moderate nausea and vomiting of pregnancy. J Midwifery Womens Health 50(1):1–3
Uchide K, Suzuki N, Takiguchi T, Terada S, Inoue M (1997) The possible effect of pregnancy on Meniere’s disease. ORL J Otorhinolaryngol Relat Spec 59(5):292–295
Kyle PM, Redman CW (1992) Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Saf 7(3):223–234
Hansen L, Sobol S, Abelson T (1986) Otolalyngologic manifestations of pregnancy. J Fam Pract 23(2):151–155
Huynh-Do U, Frey FJ (2000) Potential dangers of diuretics (article in German). Ther Umsch 57(6):408–411
Oren D, Nulman I, Makhija M, Ito S, Koren G (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 50:1083–1085
Schatz M (2001) The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 25(3):145–152
Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6):385–392
Ambro BT, Scheid SC, Pribitkin EA (2003) Prescribing guidelines for ENT medications during pregnancy. ENT J 82(8):565–568
Lockshin MD, Sammaritano LR (1998) Corticosteroids during pregnancy. Scand J Rheumatol Suppl 107:136–138
Guillonneau M, Jacqz-Aigrain E (1996) Maternal corticotherapy. Pharmacology and effect on the fetus (article in French). J Gynecol Obstet Biol Reprod (Paris) 25(2):160–167
Garbis H, Elefant E, Diav-Citrin O, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Rodriguez EP, Robert-Gnansia E, Merlob P, Peiker G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M (2005) Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 19(4):453–458
Cappell MS (2003) Gastric and duodenal ulcers during pregnancy. Gastroenterol Clin North Am 32(1):263–308
Charan M, Katz PO (2001) Gastroesophageal reflux disease in pregnancy. Curr Treat Options Gastroenterol 4(1):73–81
Michaletz-Onody PA (1992) Peptic ulcer disease in pregnancy. Gastroenterol Clin North Am 21(4):817–826
Kyle PM (2006) Drugs and the fetus. Curr Opin Obstet Gynecol 18(2):93–99
Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, De Santis M, Robert-Gnansia E, Valti E, Malm H, Ornoy A (2005) The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 21(3):269–275
Richter JE (2003) Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 32(1):235–261
Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G (2002) Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci 47(7):1526–1529
Nielsen GL, Sorensen HT, Thulstrup AM, Tage-Jensen U, Olesen C, Ekbom A (1999) The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 13(8):1085–1089
Nava-Ocampo AA, Velázquez-Armenta EY, Han JY, Koren G (2006) Use of proton pump inhibitors during pregnancy and breastfeeding. Can Fam Physician 52:853–854
Källén BA (2001) Use of omeprazole during pregnancy-no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 96(1):63–68
Tyring SK, Baker D, Snowden W (2002) Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years’ experience with acyclovir. J Infect Dis 186(Suppl 1):S40–S46
Haddad J, Messer J, Willard D, Ritter J (1989) Acyclovir and pregnancy: current aspects (article in French). J Gynecol Obstet Biol Reprod (Paris) 18(5):679–683
May M (1980) Bell’s palsy: diagnosis, prognosis and treatment. Surg Rounds 13(1):38–48
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vlastarakos, P.V., Nikolopoulos, T.P., Manolopoulos, L. et al. Treating common ear problems in pregnancy: what is safe?. Eur Arch Otorhinolaryngol 265, 139–145 (2008). https://doi.org/10.1007/s00405-007-0534-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-007-0534-3